(Q54314048)
Statements
Suppression of advanced glycation and lipoxidation end products by angiotensin II type-1 receptor blocker candesartan in type 2 diabetic patients with essential hypertension. (English)
1 reference
Yoshiaki Ono
1 reference
Kenji Mizuno
1 reference
Michihiko Takahashi
1 reference
Yukio Miura
1 reference
Tsuyoshi Watanabe
1 reference
1 January 2013
1 reference
59
1 reference
2
1 reference
69-75
1 reference
Identifiers
1 reference